• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI INTECC CO., LTD. CONFIANZA PRO 12; PTCA GUIDE WIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI INTECC CO., LTD. CONFIANZA PRO 12; PTCA GUIDE WIRE Back to Search Results
Device Problem Detachment of Device or Device Component (2907)
Patient Problem Hematoma (1884)
Event Type  Injury  
Manufacturer Narrative
Manufacturing site: manufacturing site could not be identified because the product lot number information was not available.Device evaluation could not be performed because the affected device was not returned.Lot history records review could not be conducted because lot information was unavailable.All the shipped products were inspected in the production process and satisfied the product specifications and release criteria; therefore, it was concluded that there was no anomaly in product quality.Multiple products were used in the procedure; however, how each mentioned product had caused or contributed to hematoma formation or possible vessel dissection was unable to be determined based on the limited written information.Referring to known similar events, it was presumed that patient anatomy and procedural contents were most likely associated with this event.As to detachment of the confianza pro 12 guide wire, it was unable to determine the cause due to limited information regarding how it was used during the procedure.Referring to known similar events, it was presumed that stress generated with manipulation in attempts to cross the lesion had likely contributed to separation of the guide wire.The applied stress would exceed the product design limit mostly when the wire tip was being trapped or restricted its movement by the lesion.It was concluded that this event was not attributed to product quality.Instructions for use (ifu) states: [warnings] observe movement of this guide wire in the vessels.Before this guide wire is moved or torqued, the tip movement should be examined and monitored under fluoroscopy.Do not move or torque the guide wire without observing corresponding movement of the tip; otherwise, the guide wire may be damaged and/or trauma may occur.In addition, ensure that the distal tip of this guide wire and its location in the vessel are visible during manipulations of the guide wire.Never push, auger, withdraw, or torque this guide wire that meets resistance.Torquing or pushing this guide wire against resistance may cause damage and/or tip separation of this guide wire or direct damage to a vessel.Resistance may be felt and/or observed under fluoroscopy by noting any buckling of the guide wire.If the prolapse of the guide wire tip is observed, do not allow the tip to remain in a prolapsed position; otherwise damage to the guide wire may occur.Determine the cause of resistance under fluoroscopy and take any necessary remedial action.If resistance is felt due to spasm, bending of the guide wire, or due to trap while operating this guide wire in the blood vessel or removing it, do not torque and/or pull the guide wire itself.Stop the procedure.Determine the cause of resistance under fluoroscopy and take appropriate remedial action.If the guide wire is moved excessively, it may break or become damaged, which may cause blood vessel injury or result in fragments being left inside the vessel.[malfunctions and adverse effects] vessel dissection.
 
Event Description
It was reported through a research article titled "feasibility of 5 fr contralateral radial access for hybrid chronic total occlusion percutaneous coronary intervention: experience from a single tertiary center in the (b)(6) (the journal of invasive cardiology 2019;31(6):159-165)" that identified an asahi confianza pro 12 guide wire had separated during a percutaneous coronary intervention (pci) specified as case #3.Excerpt is as follows: a (b)(6) year-old man with a background of bronchiectasis and metastatic renal cell carcinoma presented for elective cto-pci of his rca (j-cto score, 3).He had ongoing limiting stable angina despite 3 antianginal medications and significant dyspnea.Five fr access was gained via the right and left radial arteries.The 5 fr left radial access was exchanged for a 7.5 fr sheathless al 0.75 guide to engage the rca.A 5 fr ebu 4.0 guide engaged the lca via the right radial sheath.An attempt at antegrade wire escalation and adr failed; therefore, a retrograde approach was adopted.An attempt at retrograde access via lad septals was also unsuccessful, so a retrograde attempt was made via an epicardial collateral from the lcx via the atrioventricular groove branch to the posterior left ventricular (plv) artery using a sion wire (asahi intecc).A turnpike lp microcatheter (aquailant interventional) would not pass, but its retrograde path was facilitated by knuckling an antegrade wire to perform balloon trapping of the retrograde wire with an antegrade balloon.A distal hematoma occurred as a consequence, with the loss of a small posterior descending artery.During retrograde wiring, the tip of a retrograde confianza pro 12 wire became detached in the vessel.A subsequent pilot 200 wire (abbott) was then used to perform a reverse-cart procedure, which was challenging due to a large subintimal space.This then allowed pci with 4 drug-eluting stents from the plv back to the proximal rca, which resulted in timi 3 flow at completion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONFIANZA PRO 12
Type of Device
PTCA GUIDE WIRE
Manufacturer (Section D)
ASAHI INTECC CO., LTD.
3-100 akatsuki-cho
seto, aichi 489-0 071
JA  489-0071
Manufacturer (Section G)
ASAHI INTECC CO., LTD.
3-100 akatsuki-cho
seto, aichi 489-0 071
JA   489-0071
Manufacturer Contact
yukako homma
3-100 akatsuki-cho
seto, aichi 489-0-071
JA   489-0071
MDR Report Key11326739
MDR Text Key240422076
Report Number3003775027-2021-00031
Device Sequence Number1
Product Code DQX
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K171933
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 02/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/08/2021
Initial Date FDA Received02/15/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age77 YR
-
-